| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7612757
[patent_doc_number] => 06903078
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Combination PDGF, KGF, IGF, and IGFBP for wound healing'
[patent_app_type] => utility
[patent_app_number] => 09/723449
[patent_app_country] => US
[patent_app_date] => 2000-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13031
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/903/06903078.pdf
[firstpage_image] =>[orig_patent_app_number] => 09723449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/723449 | Combination PDGF, KGF, IGF, and IGFBP for wound healing | Nov 26, 2000 | Issued |
| 09/712032 | Modulation of mitochondrial mass and function for the treatment of diseases and for target and drug discovery | Nov 12, 2000 | Abandoned |
Array
(
[id] => 1014297
[patent_doc_number] => 06893637
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-17
[patent_title] => 'Method of treating fibrosis'
[patent_app_type] => utility
[patent_app_number] => 09/695121
[patent_app_country] => US
[patent_app_date] => 2000-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17808
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/893/06893637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09695121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/695121 | Method of treating fibrosis | Oct 22, 2000 | Issued |
| 09/694131 | Agents affecting the hyperactivated immunological effector cells | Oct 19, 2000 | Abandoned |
| 09/582099 | Recombinant rhabdovirus containing a heterologous fusion protein | Oct 16, 2000 | Abandoned |
| 09/685343 | Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna | Oct 10, 2000 | Abandoned |
Array
(
[id] => 366788
[patent_doc_number] => 07479536
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-01-20
[patent_title] => 'Chiral, charged peptide nucleic acid oligomers from cyclic monomers'
[patent_app_type] => utility
[patent_app_number] => 09/666144
[patent_app_country] => US
[patent_app_date] => 2000-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 5205
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/479/07479536.pdf
[firstpage_image] =>[orig_patent_app_number] => 09666144
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/666144 | Chiral, charged peptide nucleic acid oligomers from cyclic monomers | Sep 19, 2000 | Issued |
| 09/658779 | Method composition for treating tumors by selective induction of apoptosis | Sep 10, 2000 | Abandoned |
| 09/485751 | Semliki forest virus vectors for gene transfer into non-endothelial cardiovascular cells | Sep 4, 2000 | Abandoned |
Array
(
[id] => 7593202
[patent_doc_number] => 07651998
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-01-26
[patent_title] => 'Antibody dependent enhancement of Venezuelan Equine Encephalitis vector infection'
[patent_app_type] => utility
[patent_app_number] => 10/069305
[patent_app_country] => US
[patent_app_date] => 2000-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 15448
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/651/07651998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10069305
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/069305 | Antibody dependent enhancement of Venezuelan Equine Encephalitis vector infection | Aug 29, 2000 | Issued |
| 09/640887 | Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species | Aug 16, 2000 | Abandoned |
| 09/629970 | Methods and pharmaceutical compositions for healing wounds | Jul 30, 2000 | Abandoned |
Array
(
[id] => 4465054
[patent_doc_number] => 07935805
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-05-03
[patent_title] => 'Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/610313
[patent_app_country] => US
[patent_app_date] => 2000-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 30704
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935805.pdf
[firstpage_image] =>[orig_patent_app_number] => 09610313
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/610313 | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof | Jul 4, 2000 | Issued |
Array
(
[id] => 7620214
[patent_doc_number] => 06942967
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-09-13
[patent_title] => 'Target for treating athersclerosis, obesity and type II diabetes'
[patent_app_type] => utility
[patent_app_number] => 09/607437
[patent_app_country] => US
[patent_app_date] => 2000-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4259
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/942/06942967.pdf
[firstpage_image] =>[orig_patent_app_number] => 09607437
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/607437 | Target for treating athersclerosis, obesity and type II diabetes | Jun 28, 2000 | Issued |
| 09/596665 | Hyaluronic acid microspheres for sustained gene transfer | Jun 18, 2000 | Abandoned |
Array
(
[id] => 1164026
[patent_doc_number] => 06759385
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-06
[patent_title] => 'Methods to treat undesirable immune responses'
[patent_app_type] => B1
[patent_app_number] => 09/595990
[patent_app_country] => US
[patent_app_date] => 2000-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 163
[patent_no_of_words] => 61726
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759385.pdf
[firstpage_image] =>[orig_patent_app_number] => 09595990
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/595990 | Methods to treat undesirable immune responses | Jun 15, 2000 | Issued |
Array
(
[id] => 1350370
[patent_doc_number] => 06583334
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-24
[patent_title] => 'Ovariectomized mouse model for human menopause'
[patent_app_type] => B1
[patent_app_number] => 09/576838
[patent_app_country] => US
[patent_app_date] => 2000-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 52
[patent_no_of_words] => 15326
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/583/06583334.pdf
[firstpage_image] =>[orig_patent_app_number] => 09576838
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/576838 | Ovariectomized mouse model for human menopause | May 22, 2000 | Issued |
| 09/560855 | BMOG, a novel protein member of the Myelin-Oligodendrocyte glycoprotein family and its use for immunomodulatory purposes | Apr 27, 2000 | Abandoned |
Array
(
[id] => 1453182
[patent_doc_number] => 06461818
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints'
[patent_app_type] => B1
[patent_app_number] => 09/552626
[patent_app_country] => US
[patent_app_date] => 2000-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 32
[patent_no_of_words] => 10386
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461818.pdf
[firstpage_image] =>[orig_patent_app_number] => 09552626
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/552626 | Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints | Apr 18, 2000 | Issued |
Array
(
[id] => 1387369
[patent_doc_number] => 06540996
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Compound screening methods'
[patent_app_type] => B1
[patent_app_number] => 09/549872
[patent_app_country] => US
[patent_app_date] => 2000-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25510
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/540/06540996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09549872
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/549872 | Compound screening methods | Apr 13, 2000 | Issued |
